Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats
Article 2011 en
Authors
BL
Bingong Li
ZZ
Zeqi Zheng
YW
Yunfeng Wei
Abstract
1 min read
rhNRG-1 could significantly improve the heart function and reverse the cardiac remodeling of DCM rats with chronic heart failure. These results support the clinical possibility of applying rhNRG-1 as an optional therapeutic strategy for DCM treatment in the future.
Hong Wei, Djahida Bedja, Norimichi Koitabashi, Dongmei Xing, Jasper Chen, Karen Fox-Talbot, Rosanne Rouf, Shaoping Chen, Charles Steenbergen, John W. Harmon, Harry C. Dietz, Kathleen L. Gabrielson, David A. Kass, Gregg L. Friedman
Maija Bry, Riikka Kivelä, Tanja Holopainen, Andrey Anisimov, Tuomas Tammela, Jarkko Soronen, Johanna M. U. Silvola, Antti Saraste, Michael Jeltsch, Petra Korpisalo, Peter Carmeliet, Karl Lemström, Masabumi Shibuya, Seppo Ylä‐Herttuala, Leena Alhonen, Eero Mervaala, Leif C. Andersson, Juhani Knuuti, Kari Alitalo
Faı̈ez Zannad, Wendy Gattis Stough, Patrick Rossignol, Johann Bauersachs, John J.V. McMurray, Karl Swedberg, Allan D. Struthers, A.A. Voors, Luís M. Ruilope, G. Bakris, Christopher M. O’Connor, Mihai Gheorghiade, Robert J. Mentz, A Cohen-Solal, Aldo Maggioni, Farzin Beygui, Gerasimos Filippatos, Ziad A. Massy, Atul Pathak, Ileana L. Piña, Hani N. Sabbah, Domenic A. Sica, ,
Discussion(0)
No comments yet. Be the first to comment.